APC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_APC_073012
C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
  • 17A2_APC_073012
    C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Save
100235 25 µg ¥6,930
100236 100 µg ¥16,170
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  2. Liu J, et al. 2019. Immunity. 50:600. PubMed
  3. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  4. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  5. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  6. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  7. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  8. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  9. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  10. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  11. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  12. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  13. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  14. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  15. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  16. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  17. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  18. Sano T, et al. 2021. Cell Reports. 36(8):109608. PubMed
  19. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  20. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  21. Baram T, et al. 2021. Cells. 10:. PubMed
  22. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  23. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  24. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  25. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  26. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  27. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  28. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  29. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  30. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  31. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  32. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  33. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  34. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  35. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  36. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  37. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  38. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  39. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  40. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  41. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  42. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  43. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  44. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  45. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  46. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  47. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  48. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  49. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  50. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  51. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  52. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  53. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  54. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  55. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  56. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  57. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  58. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  59. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  60. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  61. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  62. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  63. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  64. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  65. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  66. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  67. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  68. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  69. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  70. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  71. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  72. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  73. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  74. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  75. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  76. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  77. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  78. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  79. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  80. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  81. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  82. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  83. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  84. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  85. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  86. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  87. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  88. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  89. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  90. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  91. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  92. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  93. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  94. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  95. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  96. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  97. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  98. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  99. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  100. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  101. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  102. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  103. Zhang J, et al. 2018. Nature. 553:91. PubMed
  104. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  105. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  106. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  107. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  108. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  109. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  110. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  111. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  112. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  113. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  114. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  115. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  116. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  117. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  118. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  119. Kim S, et al. 2020. Autophagy. :1. PubMed
  120. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  121. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  122. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  123. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  124. Kelley WJ, et al. 2022. JCI Insight. :. PubMed
  125. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  126. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  127. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  128. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  129. Li H, et al. 2022. iScience. 25:104481. PubMed
  130. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  131. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  132. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  133. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  134. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  135. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  136. Zeng A, et al. 2020. Oncol Rep. . PubMed
  137. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  138. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  139. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  140. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  141. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  142. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  143. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  144. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  145. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  146. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  147. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  148. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  149. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
RRID
AB_2561455 (BioLegend Cat. No. 100235)
AB_2561456 (BioLegend Cat. No. 100236)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC, IHC-F, IP, ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC, IHC-F, 3D IHC
Alexa Fluor® 488 anti-mouse CD3 17A2 FC, IHC-F, 3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC, ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC, IHC-F, IP, ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F, FC, 3D IHC, SB
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC, IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC

Customers Also Purchased

Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • FITC anti-mouse CD3

  • PE anti-mouse CD3

  • Purified anti-mouse CD3

  • Alexa Fluor® 647 anti-mouse CD3

  • Alexa Fluor® 488 anti-mouse CD3

  • Pacific Blue™ anti-mouse CD3

  • Alexa Fluor® 700 anti-mouse CD3

  • PerCP/Cyanine5.5 anti-mouse CD3

  • PE/Cyanine7 anti-mouse CD3

  • APC/Cyanine7 anti-mouse CD3

  • Brilliant Violet 421™ anti-mouse CD3

  • Brilliant Violet 570™ anti-mouse CD3

  • Brilliant Violet 650™ anti-mouse CD3

  • Brilliant Violet 785™ anti-mouse CD3

  • Brilliant Violet 510™ anti-mouse CD3

  • APC anti-mouse CD3

  • Ultra-LEAF™ Purified anti-mouse CD3

  • Brilliant Violet 605™ anti-mouse CD3

  • Alexa Fluor® 594 anti-mouse CD3

  • Brilliant Violet 711™ anti-mouse CD3

  • Biotin anti-mouse CD3

  • PE/Dazzle™ 594 anti-mouse CD3

  • APC/Fire™ 750 anti-mouse CD3

  • Brilliant Violet 750™ anti-mouse CD3

  • TotalSeq™-A0182 anti-mouse CD3

  • TotalSeq™-B0182 anti-mouse CD3

  • Spark Blue™ 550 anti-mouse CD3

  • Spark NIR™ 685 anti-mouse CD3

  • TotalSeq™-C0182 anti-mouse CD3

  • APC/Fire™ 810 anti-mouse CD3

  • PE/Fire™ 640 anti-mouse CD3

  • Spark YG™ 570 anti-mouse CD3

  • PE/Fire™ 700 anti-mouse CD3

  • PE/Cyanine5 anti-mouse CD3

  • Spark Blue™ 574 anti-mouse CD3 Antibody

  • Spark Violet™ 423 anti-mouse CD3

  • PE/Fire™ 810 anti-mouse CD3

  • Spark Red™ 718 anti-mouse CD3

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account